FIELD: veterinary medicine.
SUBSTANCE: group of inventions relates to medicine, specifically to veterinary medicine, and can be used to prevent infections caused by the Hendra and/or Nipah virus in a horse or a pig. For this purpose, a vaccine is administered containing 50–100 mcg of a soluble fragment of Hendra virus G glycoprotein, which consists of amino acids 73-604 SEQ ID NO: 2 or a sequence which is at least 95 % identical. Vaccine also contains an immunostimulatory complex and excipients. In addition, a method for preventing a Hendra and/or Nipah virus infection in a horse or a pig and a method for differentiating a subject vaccinated with said vaccine from a subject exposed to Hendra and/or Nipah virus are disclosed.
EFFECT: group of inventions allows to prevent infection caused by the Hendra and/or Nipah virus in a horse or a pig.
13 cl, 9 tbl, 6 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITIONS OF GLYCOPROTEIN G OF HENDRA AND NIPAH VIRUSES | 2012 |
|
RU2787820C2 |
| OIL-BASED ADJUVANTS | 2014 |
|
RU2816851C2 |
| OIL-BASED ADJUVANTS | 2014 |
|
RU2816849C2 |
| OIL-BASED ADJUVANTS | 2014 |
|
RU2730011C2 |
| NEW VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2014 |
|
RU2627447C2 |
| VACCINES AND METHODS OF TREATING CANINE INFLUENZA | 2006 |
|
RU2396976C2 |
| IMMUNOGENIC MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) COMPOSITIONS AND METHODS | 2014 |
|
RU2685185C2 |
| INFLUENZA VACCINE | 2011 |
|
RU2583297C2 |
| FOOT-AND-MOUTH DISEASE VACCINE | 2016 |
|
RU2698305C2 |
| NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
